Clinical trial · Interventional
Treatment Preference and Patient Centered Prostate Cancer Care
NCT02032550CI-TRIAL-00046400completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to develop a preference based decision aid to assess the treatment preferences of prostate cancer patients, and to analyze the interaction of treatment preferences, type of treatment received and their relationship with health related quality of life, satisfaction with care, decision regret, and psychological health of men with localized prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Preference Based Decision Aid | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Preference Based Decision Aid
- description
- The experimental arm of preference based decision aid intervention will complete a web-based conjoint analysis instrument for preference assessment.
- interventionNames
- Other: Preference Based Decision Aid
- type
- NO_INTERVENTION
- label
- Usual Care
- description
- Participants randomized into this group will have usual care from their doctors without any intervention
Primary outcomes (1)
- measure
- Change in Satisfaction With Care
- timeFrame
- baseline, 3, 6, 12 and 24 months
- description
- The investigators will measure Satisfaction with Care (PSQ-18). : The PSQ-18 scale measures satisfaction with care at baseline 3, 6, 12, and 24 months. Higher score indicates better satisfaction with care. Positive change indicates improvement in satisfaction with care.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Newly diagnosed with non-metastatic prostate cancer 2. Has not yet started radiation or surgery 3. Provide informed consent Exclusion Criteria: 1. Distant, metastatic prostate cancer at diagnosis 2. Has already begun treatment for prostate cancer 3. Unable to communicate in English
References
Publications (1)
- DERIVEDChhatre S, Jefferson A, Cook R, Meeker CR, Kim JH, Hartz KM, Wong YN, Caruso A, Newman DK, Morales KH, Jayadevappa R. Patient-centered recruitment and retention for a randomized controlled study. Trials. 2018 Mar 27;19(1):205. doi: 10.1186/s13063-018-2578-7. PMID 29587805